Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.06
+6.04%
Mkt Cap $6.34M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | — | -$0.03 | — |
| Q4 2025 Nov 13, 2025 | — | — | — | — | -$0.07 | — |
| Q4 2025 Oct 3, 2025 | — | — | — | — | -$0.05 | — |